NCT02439047 2026-03-16
MESO-PATCH
Centre Oscar Lambret
Phase NA Terminated
Clinical Trials
247 trialsNCT05477784 2026-01-21
EC-PC
University of Washington
Phase NA Terminated
NCT05450562 2026-01-14
Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors
Sanofi
Phase 1/2 Terminated
NCT04824859 2026-01-05
eGAP
University of Rochester
Phase NA Terminated
NCT06162351 2026-01-02
TOPOLOGY
Institut Curie
Phase 2 Terminated
NCT05694013 2025-10-22
ORIGAMA
Hoffmann-La Roche
Phase 2/3 Terminated
NCT06523803 2025-10-21
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
Zymeworks BC Inc.
Phase 1 Terminated
NCT06175221 2025-09-15
Autologous TLPO Vaccine Basket
Elios Therapeutics, LLC
Phase 2 Terminated
NCT03971266 2025-09-02
Movement and Fitness Trackers in Determining Performance Status
University of Southern California
Phase NA Terminated
NCT06877533 2025-08-12
A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors
iTeos Therapeutics
Phase 1 Terminated
NCT04717375 2025-08-07
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors
Sanofi
Phase 1/2 Terminated
NCT03057639 2025-07-25
Clinical Model in Evaluating Clinical, Psychosocial, and Health Economic Factors in Adolescent and Young Adult Patients With Cancer
University of Southern California
Terminated
NCT02420509 2025-06-04
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
University of California, San Diego
Terminated
NCT06790303 2025-06-04
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2
GlaxoSmithKline
Phase 2 Terminated
NCT01369641 2025-05-16
The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy
Thomas Jefferson University
Phase NA Terminated
NCT01871441 2025-05-16
Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Thomas Jefferson University
Phase 2 Terminated
NCT04875871 2025-05-11
PARTICLE-PATHY
EBG MedAustron GmbH
Phase NA Terminated
NCT02170350 2025-04-29
Brief Mindful Meditation Practice in Improving Quality of Life in Patients With Cancer Undergoing Radiation Therapy
Thomas Jefferson University
Phase NA Terminated
NCT05840510 2025-04-25
Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)
Mirati Therapeutics Inc.
Phase 1 Terminated
NCT05429762 2025-04-06
TusaRav-QT
Sanofi
Phase 1 Terminated
NCT03752203 2025-03-06
Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors
University of Colorado, Denver
Phase NA Terminated
NCT00748709 2025-02-11
Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification.
Boehringer Ingelheim
Phase 2 Terminated
NCT02187848 2025-02-10
Evaluation of SAR408701 in Patients With Advanced Solid Tumors
Sanofi
Phase 1 Terminated
NCT03839940 2025-01-29
MIST
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT03599661 2025-01-09
Developing and Validating Fertilit-e
Wake Forest University Health Sciences
Terminated
NCT05244915 2025-01-06
A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer
University of Rochester
Phase NA Terminated
NCT04528836 2024-12-12
First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors
Navire Pharma Inc., a BridgeBio company
Phase 1 Terminated
NCT05062447 2024-12-10
EMOCA
Amsterdam UMC, location VUmc
Terminated
NCT06290388 2024-12-04
Study of 23ME-01473 in Patients With Advanced Solid Malignancies
23andMe, Inc.
Phase 1/2 Terminated
NCT03915717 2024-11-26
Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring
Sonavex, Inc.
Terminated
NCT05525455 2024-11-21
TT-816 As Monotherapy or in Combination with a PD-1 Inhibitor in Patients with Advanced Cancers (SEABEAM) (MK3475-E88)
Teon Therapeutics, Inc.
Phase 1/2 Terminated
NCT03979794 2024-11-14
A Distress Screening and Intervention in Cancer Surgery
Baylor College of Medicine
Phase NA Terminated
NCT03783403 2024-09-19
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
Celgene
Phase 1 Terminated
NCT04768153 2024-08-21
RESILIENCE
University Hospital Center of Martinique
Terminated
NCT04534283 2024-08-07
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.
Indiana University
Phase 2 Terminated
NCT06160700 2024-06-10
Serial Testing To Assess Cognitive Function In Cancer
Indiana University
Terminated
NCT03416335 2024-05-30
A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile
Sumitomo Pharma America, Inc.
Phase 1/2 Terminated
NCT04618393 2024-05-21
A Study of EMB-02 in Participants With Advanced Solid Tumors
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1/2 Terminated
NCT00657098 2024-05-03
Mabtornib
University Medical Center Groningen
Terminated
NCT04349280 2024-04-18
A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer
GlaxoSmithKline
Phase 1 Terminated
NCT01243333 2024-04-17
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
University of Utah
Phase NA Terminated
NCT03885908 2024-03-25
Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Terminated
NCT00250055 2024-03-12
Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue
University of New Mexico
Phase NA Terminated
NCT03604445 2024-03-04
This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours)
Boehringer Ingelheim
Phase 1 Terminated
NCT05133128 2024-02-22
IMMUNOPBMC
Servier
Phase NA Terminated
NCT00277004 2024-02-07
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.
University of New Mexico
Terminated
NCT06004141 2024-02-02
LAGUNA
Massachusetts General Hospital
Phase NA Terminated
NCT03300310 2024-02-01
IPIO-PA
Nantes University Hospital
Phase NA Terminated
NCT01311713 2024-01-30
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 1/2 Terminated
NCT03874065 2024-01-19
Medical Data Collection in the Formation of Precision Oncology Registry
Wake Forest University Health Sciences
Terminated